10 June 2021

PRIIPs Regulation: Further postponement for the fund industry announced

The European Commission recently announced a renewed extension of the transitional PRIIPs KID regime for the fund industry until 30 June 2022.

The renewed extension plans are caused by a lengthy coordination process among the European Supervisory Authorities (ESAs) on technical standards (RTS) for the PRIIPs Regulation which reconciled the draft RTS at the beginning of March 2021. The final RTS are not expected to be published until the fourth quarter of this year. Hence, the European Commission proposed to apply the PRIIPs requirements for the fund industry six months later. Accordingly, investment funds and distributors will not be required to prepare key investor information in the form of a PRIIPs KID or make it available to retail investors as part of an advisory service or distribution before July 1, 2022. We assume that the amendment will be implemented shortly via quick-fix procedure.

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 10 June 2021

    GSK Update: PRIIPs Regulation: Further postponement for the fund industry announced

    Read more
  • 08 June 2021

    GSK Update: Autonomous driving: From vision to reality – German Autonomous Driving Act comes into force

    Read more
  • 17 May 2021

    GSK Update: 17th Amendment to the Foreign Trade and Payments Ordinance now in force

    Read more
Contact person

Robert Kramer

Partner*

+49 89 288174-662

robert.kramer@gsk.de

Philippe Lorenz

Local Partner*

+49 89 288174-662

philippe.lorenz@gsk.de

Katharina Herdl

Associate

+49 89 288174-31

katharina.herdl@gsk.de

Irina Stoliarova, LL.M.

Senior Associate

+352 271802-52

irina.stoliarova@gsk-lux.com

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral